<VariationArchive VariationID="2113806" VariationName="NM_001323289.2(CDKL5):c.1506dup (p.Glu503Ter)" VariationType="Duplication" Accession="VCV002113806" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2171701" VariationID="2113806">
      <GeneList>
        <Gene Symbol="CDKL5" FullName="cyclin dependent kinase like 5" GeneID="6792" HGNC_ID="HGNC:11411" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18425608" stop="18653629" display_start="18425608" display_stop="18653629" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18443724" stop="18671748" display_start="18443724" display_stop="18671748" Strand="+" />
          </Location>
          <OMIM>300203</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKL5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKL5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001323289.2(CDKL5):c.1506dup (p.Glu503Ter)</Name>
      <CanonicalSPDI>NC_000023.11:18604429:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18604429" stop="18604430" display_start="18604429" display_stop="18604430" variantLength="1" positionVCF="18604429" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18622549" stop="18622550" display_start="18622549" display_stop="18622550" variantLength="1" positionVCF="18622549" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>E503*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.18622550dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.18622550dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.18604430dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.18604430dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008475.1" sequenceAccession="NG_008475" sequenceVersion="1" change="g.183826dup">
            <Expression>NG_008475.1:g.183826dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001037343.2" sequenceAccession="NM_001037343" sequenceVersion="2" change="c.1506dup">
            <Expression>NM_001037343.2:c.1506dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001032420.1" sequenceAccession="NP_001032420" sequenceVersion="1" change="p.Glu503Ter">
            <Expression>NP_001032420.1:p.Glu503Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323289.2" sequenceAccession="NM_001323289" sequenceVersion="2" change="c.1506dup" MANESelect="true">
            <Expression>NM_001323289.2:c.1506dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310218.1" sequenceAccession="NP_001310218" sequenceVersion="1" change="p.Glu503Ter">
            <Expression>NP_001310218.1:p.Glu503Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003159.3" sequenceAccession="NM_003159" sequenceVersion="3" change="c.1506dup">
            <Expression>NM_003159.3:c.1506dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003150.1" sequenceAccession="NP_003150" sequenceVersion="1" change="p.Glu503Ter">
            <Expression>NP_003150.1:p.Glu503Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001323289.2(CDKL5):c.1506dup (p.Glu503Ter) AND multiple conditions" Accession="RCV003038962" Version="2">
        <ClassifiedConditionList TraitSetID="10061">
          <ClassifiedCondition DB="MedGen" ID="CN128785">Angelman syndrome-like</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4750718">Developmental and epileptic encephalopathy, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22872100</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10061" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17019" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Angelman syndrome-like</ElementValue>
              </Name>
              <XRef ID="CN128785" DB="MedGen" />
            </Trait>
            <Trait ID="2108" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 2</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+2/8342" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 2</ElementValue>
                <XRef ID="MONDO:0010396" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE SPASM SYNDROME, X-LINKED 2</ElementValue>
                <XRef Type="MIM" ID="300672" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE2</ElementValue>
                <XRef Type="MIM" ID="300672" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ISSX2</ElementValue>
                <XRef Type="MIM" ID="300672" DB="OMIM" />
              </Symbol>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="3451" DB="Orphanet" />
              <XRef ID="505652" DB="Orphanet" />
              <XRef ID="C4750718" DB="MedGen" />
              <XRef ID="MONDO:0010396" DB="MONDO" />
              <XRef Type="MIM" ID="300672" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6020203" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16178360|MedGen:C1839333;CN128785" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003336815" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22872100</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CDKL5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu503*) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.18622549_18622550insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839333" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN128785" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6020203" TraitType="Disease" MappingType="XRef" MappingValue="C1839333" MappingRef="MedGen">
        <MedGen CUI="C4750718" Name="Developmental and epileptic encephalopathy, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6020203" TraitType="Disease" MappingType="XRef" MappingValue="CN128785" MappingRef="MedGen">
        <MedGen CUI="CN128785" Name="Angelman syndrome-like" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

